1 min read

HKG:1177 Sino Biopharm

HKG:1177 Sino Biopharm operates in the field of Medicine. The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

HKG:1177 Sino Biopharm

Last update: 5-Jun-24

Quick overview:

    • Yield: 1.76%

(See here Top 10 highest yield)

    • Lot: 1000
    • Price/Earnings ratio : 23.67 (Ideal <20 )
    • Earnings per share : 0.120 (Ideal >0.001)
    • Price as per 5-Jun-24 : HK$2.84
    • Ex-Dividend Date coming up:  11-Jun-24

See here all upcoming Ex-Dividend dates

Log in, to see this page

Get access to expert data in 5 minutes

 

Start here:

your FREE Dividend Growth and Blue Chip kit

  • Top 25 highest yield dividend growth companies

  • All Hong Kong Blue Chip stocks (incl P/E and EPS)

  • Stock of the week, in your mail box (only 1 mail per week)

 

YES, FOR FREE

No spam, promise!